No abstract available
MeSH terms
-
Animals
-
Brentuximab Vedotin
-
Clinical Trials, Phase I as Topic / trends
-
Hodgkin Disease / drug therapy
-
Humans
-
Immunoconjugates / therapeutic use*
-
Ki-1 Antigen / immunology*
-
Lymphoma, Large-Cell, Anaplastic / drug therapy
Substances
-
Immunoconjugates
-
Ki-1 Antigen
-
Brentuximab Vedotin